DNAVision has appointed Laurent Alexandre to serve as president and chairman of the board. In this position, he will lead the company’s personalized medicine and consumer genomics business.
Alexandre founded two French public companies, Medcost and Doctissimo, and participated in the development of Benefit, a clinical research company.
Intrexon has appointed Thomas Goralski as president of its ultravector division and senior vice president of the corporation.
Goralski has worked in various leadership roles at Incyte Genomics, Perlegen Sciences, and at Expression Analysis.
Population Diagnostics has appointed Peggy Eis as chief technology officer, a role in which she will work to scale up the firm’s biomarker discovery platform.
Eis previously was senior director of genome variation at Roche NimbleGen, and was head of the CGH microarray business at NimbleGen. She also led DNA and RNA detection development at Third Wave Technologies.